Objectives: Comparison of Effects Different Doses of Vitamin D Supplementation on Pregnancy Outcomes in Gestational Diabetes women. Design: Randomized, single-blind, ِDouble-center, phase II trial. Setting and conduct: For Group A, two times the baseline and day 21 of the study, vitamin IU D3 400 is administered.For Group B, two times the baseline and day 21 of the study, vitamin IU D3 50000 is administered.For Group Control, two times the baseline and day 21 of the study, placebo is administered. 10 days after delivery, outcomes pregnancy of patient is evaluated. Participants including major eligibility criteria: Inclusion criteria include: Pregnant women with gestational diabetes who have inadequate levels of vitamin D; exclusion criteria include: Irregular consumption of prescribed supplements. Intervention: For Group A, two times the baseline and day 21 of the study, vitamin IU D3 400 is administered.For Group B, two times the baseline and day 21 of the study, vitamin IU D3 50000 is administered.For Group Control, two times the baseline and day 21 of the study, placebo is administered. Main outcome measures variable: outcomes pregnancy after taking the supplements.